Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: Q4QA54
Term | Name | Level | Count |
---|---|---|---|
GO:0001731 | formation of translation preinitiation complex | 7 | 2 |
GO:0002183 | cytoplasmic translational initiation | 4 | 2 |
GO:0002188 | translation reinitiation | 5 | 2 |
GO:0006413 | translational initiation | 3 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 2 |
GO:0043933 | protein-containing complex organization | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0065003 | protein-containing complex assembly | 5 | 2 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 8 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0003743 | translation initiation factor activity | 4 | 8 |
GO:0005488 | binding | 1 | 8 |
GO:0008135 | translation factor activity, RNA binding | 3 | 8 |
GO:0045182 | translation regulator activity | 1 | 8 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 8 |
GO:1901363 | heterocyclic compound binding | 2 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 165 | 169 | PF00656 | 0.490 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.450 |
CLV_NRD_NRD_1 | 176 | 178 | PF00675 | 0.482 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.313 |
CLV_NRD_NRD_1 | 235 | 237 | PF00675 | 0.334 |
CLV_NRD_NRD_1 | 94 | 96 | PF00675 | 0.775 |
CLV_PCSK_FUR_1 | 174 | 178 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.524 |
CLV_PCSK_KEX2_1 | 208 | 210 | PF00082 | 0.313 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.286 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.331 |
CLV_PCSK_PC1ET2_1 | 175 | 177 | PF00082 | 0.513 |
CLV_PCSK_PC1ET2_1 | 208 | 210 | PF00082 | 0.313 |
CLV_PCSK_PC1ET2_1 | 237 | 239 | PF00082 | 0.300 |
CLV_PCSK_PC7_1 | 172 | 178 | PF00082 | 0.465 |
CLV_PCSK_PC7_1 | 233 | 239 | PF00082 | 0.283 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.478 |
CLV_PCSK_SKI1_1 | 192 | 196 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.280 |
DEG_SPOP_SBC_1 | 28 | 32 | PF00917 | 0.612 |
DOC_CKS1_1 | 55 | 60 | PF01111 | 0.680 |
DOC_MAPK_gen_1 | 195 | 203 | PF00069 | 0.514 |
DOC_MAPK_gen_1 | 276 | 284 | PF00069 | 0.554 |
DOC_MAPK_gen_1 | 84 | 93 | PF00069 | 0.573 |
DOC_USP7_MATH_1 | 278 | 282 | PF00917 | 0.485 |
DOC_USP7_UBL2_3 | 97 | 101 | PF12436 | 0.790 |
DOC_WW_Pin1_4 | 54 | 59 | PF00397 | 0.696 |
LIG_14-3-3_CanoR_1 | 176 | 185 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 212 | 221 | PF00244 | 0.503 |
LIG_14-3-3_CanoR_1 | 236 | 245 | PF00244 | 0.513 |
LIG_Actin_RPEL_3 | 185 | 204 | PF02755 | 0.523 |
LIG_Actin_WH2_2 | 214 | 231 | PF00022 | 0.504 |
LIG_deltaCOP1_diTrp_1 | 234 | 239 | PF00928 | 0.457 |
LIG_FHA_1 | 28 | 34 | PF00498 | 0.567 |
LIG_FHA_2 | 178 | 184 | PF00498 | 0.469 |
LIG_FHA_2 | 77 | 83 | PF00498 | 0.544 |
LIG_GBD_Chelix_1 | 263 | 271 | PF00786 | 0.257 |
LIG_LIR_Apic_2 | 273 | 278 | PF02991 | 0.500 |
LIG_LIR_LC3C_4 | 120 | 125 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 132 | 138 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 147 | 151 | PF02991 | 0.452 |
LIG_Pex14_1 | 235 | 239 | PF04695 | 0.457 |
LIG_SH2_CRK | 135 | 139 | PF00017 | 0.438 |
LIG_SH2_CRK | 275 | 279 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.422 |
LIG_SH3_3 | 288 | 294 | PF00018 | 0.513 |
LIG_SUMO_SIM_anti_2 | 199 | 205 | PF11976 | 0.292 |
LIG_SUMO_SIM_par_1 | 120 | 126 | PF11976 | 0.573 |
LIG_SUMO_SIM_par_1 | 199 | 205 | PF11976 | 0.351 |
LIG_TRAF2_1 | 118 | 121 | PF00917 | 0.574 |
LIG_TRAF2_1 | 247 | 250 | PF00917 | 0.457 |
LIG_TYR_ITIM | 133 | 138 | PF00017 | 0.453 |
MOD_CK1_1 | 7 | 13 | PF00069 | 0.612 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.724 |
MOD_CK2_1 | 76 | 82 | PF00069 | 0.661 |
MOD_Cter_Amidation | 172 | 175 | PF01082 | 0.454 |
MOD_Cter_Amidation | 210 | 213 | PF01082 | 0.300 |
MOD_Cter_Amidation | 286 | 289 | PF01082 | 0.546 |
MOD_GlcNHglycan | 147 | 151 | PF01048 | 0.470 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.619 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.708 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.756 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.556 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.500 |
MOD_NEK2_1 | 270 | 275 | PF00069 | 0.500 |
MOD_NEK2_2 | 278 | 283 | PF00069 | 0.478 |
MOD_PKA_1 | 237 | 243 | PF00069 | 0.514 |
MOD_PKA_2 | 237 | 243 | PF00069 | 0.515 |
MOD_PKA_2 | 63 | 69 | PF00069 | 0.679 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.505 |
MOD_Plk_4 | 278 | 284 | PF00069 | 0.472 |
MOD_ProDKin_1 | 54 | 60 | PF00069 | 0.696 |
MOD_SUMO_rev_2 | 105 | 109 | PF00179 | 0.662 |
TRG_DiLeu_BaEn_1 | 280 | 285 | PF01217 | 0.549 |
TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.490 |
TRG_ER_diArg_1 | 174 | 177 | PF00400 | 0.471 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.504 |
TRG_ER_diArg_1 | 235 | 238 | PF00400 | 0.534 |
TRG_NLS_Bipartite_1 | 80 | 100 | PF00514 | 0.609 |
TRG_NLS_MonoCore_2 | 173 | 178 | PF00514 | 0.446 |
TRG_NLS_MonoExtC_3 | 287 | 292 | PF00514 | 0.525 |
TRG_NLS_MonoExtC_3 | 94 | 99 | PF00514 | 0.580 |
TRG_NLS_MonoExtN_4 | 172 | 179 | PF00514 | 0.446 |
TRG_NLS_MonoExtN_4 | 233 | 240 | PF00514 | 0.500 |
TRG_NLS_MonoExtN_4 | 3 | 9 | PF00514 | 0.605 |
TRG_NLS_MonoExtN_4 | 95 | 100 | PF00514 | 0.594 |
TRG_Pf-PMV_PEXEL_1 | 177 | 181 | PF00026 | 0.506 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IAD2 | Leptomonas seymouri | 59% | 100% |
A0A3Q8ICD2 | Leishmania donovani | 92% | 100% |
A4HDY3 | Leishmania braziliensis | 79% | 99% |
A4I184 | Leishmania infantum | 91% | 100% |
D0A5G8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
E9AXB8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |